Cited 16 times in
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신성재 | - |
dc.date.accessioned | 2016-02-04T11:51:10Z | - |
dc.date.available | 2016-02-04T11:51:10Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1871-5206 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/141346 | - |
dc.description.abstract | Intermittent three-times-weekly antibiotic therapy is recommended for the initial treatment of patients with noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease. Although some experts recommend switching from intermittent to daily therapy for patients whose sputum has persistent positive cultures after intermittent therapy, the clinical efficacy of these modifications is unknown. Of 20 patients whose sputum had persistent positive cultures after 12 months of intermittent antibiotic therapy, specimens from 6 patients (30%) achieved a negative culture after a change to daily therapy. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 4994~4996 | - |
dc.relation.isPartOf | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Anti-Bacterial Agents/administration & dosage* | - |
dc.subject.MESH | Bronchiectasis/drug therapy* | - |
dc.subject.MESH | Bronchiectasis/microbiology* | - |
dc.subject.MESH | Clarithromycin/administration & dosage | - |
dc.subject.MESH | Drug Therapy, Combination/methods | - |
dc.subject.MESH | Ethambutol/administration & dosage | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lung/microbiology | - |
dc.subject.MESH | Lung Diseases/diet therapy* | - |
dc.subject.MESH | Lung Diseases/microbiology* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Mycobacterium avium Complex/drug effects* | - |
dc.subject.MESH | Mycobacterium avium-intracellulare Infection/drug therapy* | - |
dc.subject.MESH | Sputum/microbiology | - |
dc.title | Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Microbiology (미생물학) | - |
dc.contributor.googleauthor | Won-Jung Koh | - |
dc.contributor.googleauthor | Byeong-Ho Jeong | - |
dc.contributor.googleauthor | Kyeongman Jeon | - |
dc.contributor.googleauthor | Hye Yun Park | - |
dc.contributor.googleauthor | Su-Young Kim | - |
dc.contributor.googleauthor | Hee Jae Huh | - |
dc.contributor.googleauthor | Chang-Seok Ki | - |
dc.contributor.googleauthor | Nam Yong Lee | - |
dc.contributor.googleauthor | Sung Jae Shin | - |
dc.contributor.googleauthor | Charles L. Daley | - |
dc.identifier.doi | 10.1128/AAC.00648-15 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02114 | - |
dc.relation.journalcode | J00186 | - |
dc.identifier.eissn | 1875-5992 | - |
dc.identifier.pmid | 25987622 | - |
dc.identifier.url | http://aac.asm.org/content/59/8/4994.long | - |
dc.contributor.alternativeName | Shin, Sung Jae | - |
dc.contributor.affiliatedAuthor | Shin, Sung Jae | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 59 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 4994 | - |
dc.citation.endPage | 4996 | - |
dc.identifier.bibliographicCitation | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, Vol.59(8) : 4994-4996, 2015 | - |
dc.identifier.rimsid | 30588 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.